Accepted for Publication: May 20, 2021.
Published Online: August 19, 2021. doi:10.1001/jamaoncol.2021.3067
Corresponding Author: Kerry S. Courneya, PhD, Faculty of Kinesiology, Sport, and Recreation, University of Alberta, 1-113 University Hall, Edmonton, Alberta T6G 2H9, Canada (kerry.courneya@ualberta.ca).
Author Contributions: Dr Kang and Prof Courneya had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Kang, Fairey, Boulé, Courneya.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Kang.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Kang, Fairey, Boulé, Courneya.
Obtained funding: Kang, Courneya.
Administrative, technical, or material support: Kang, Fairey, Wharton, Courneya.
Supervision: Kang, Fairey, Boulé, Field, Courneya.
Conflict of Interest Disclosures: None reported.
Funding/Support: This study was supported by grant 389507 from the Canadian Institutes of Health Research and grant D2017-1820 from Prostate Cancer Canada. Prof Courneya was supported by the Canada Research Chairs Program. Dr Kang was supported by the Alberta Innovates Graduate Studentship. Exercise equipment was donated by Apple Fitness, Edmonton, Alberta, Canada.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Data Sharing Statement: See Supplement 3.
Additional Contributions: We acknowledge the support of the following individuals: Niels-Erik Jacobsen, MD, Michael Chetner, MD, Sarah Rayner, RN, and Nupur Agarwal, CCPA, Northern Alberta Urology Center, assisted with patient recruitment; Sue Goruk, PhD, and Dhruvesh Patel, BSc, University of Alberta, assisted with blood assays; and Andria Morielli, PhD, Terri Wood, BSc, Ki-Yong An, PhD, Fernanda Arthuso, MSc, Stephanie Ntoukas, BSc, Spencer Allen, BSc, and Morgan Corbett, BSc, University of Alberta, assisted with exercise testing and intervention. These individuals received no additional compensation, outside of their usual salary, for their contributions. We also thank the study participants for their time and commitment.
1.Mahal
BA , Butler
S , Franco
I ,
et al. Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015.
JAMA. 2019;321(7):704-706. doi:
10.1001/jama.2018.19941
PubMedGoogle ScholarCrossref 3.Neal
DE , Metcalfe
C , Donovan
JL ,
et al; ProtecT Study Group. Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received.
Eur Urol. 2020;77(3):320-330. doi:
10.1016/j.eururo.2019.10.030
PubMedGoogle ScholarCrossref 5.Keegan
KA , Dall’Era
MA , Durbin-Johnson
B , Evans
CP . Active surveillance for prostate cancer compared with immediate treatment: an economic analysis.
Cancer. 2012;118(14):3512-3518. doi:
10.1002/cncr.26688
PubMedGoogle ScholarCrossref 9.Hvid
T , Lindegaard
B , Winding
K ,
et al. Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patients.
Cancer Causes Control. 2016;27(2):165-174. doi:
10.1007/s10552-015-0694-1
PubMedGoogle ScholarCrossref 11.Demark-Wahnefried
W , Rais-Bahrami
S , Desmond
RA ,
et al. Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.
Br J Cancer. 2017;117(9):1303-1313. doi:
10.1038/bjc.2017.303
PubMedGoogle ScholarCrossref 13.Kang
DW , Fairey
AS , Boulé
NG , Field
CJ , Courneya
KS . Exercise during active surveillance for prostate cancer-the ERASE trial: a study protocol of a phase II randomised controlled trial.
BMJ Open. 2019;9(7):e026438. doi:
10.1136/bmjopen-2018-026438
PubMedGoogle Scholar 14.Kodama
S , Saito
K , Tanaka
S ,
et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
JAMA. 2009;301(19):2024-2035. doi:
10.1001/jama.2009.681
PubMedGoogle ScholarCrossref 16.Beltz
NM , Gibson
AL , Janot
JM , Kravitz
L , Mermier
CM , Dalleck
LC . Graded exercise testing protocols for the determination of VO
2max: historical perspectives, progress, and future considerations.
J Sports Med (Hindawi Publ Corp). 2016;2016:3968393. doi:
10.1155/2016/3968393
PubMedGoogle Scholar 18.Rikli
RE , Jones
CJ . Senior Fitness Test Manual. Human Kinetics; 2013.
19.American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. Lippincott Williams & Wilkins; 2013.
20.Godin
G , Shephard
RJ . A simple method to assess exercise behavior in the community.
Can J Appl Sport Sci. 1985;10(3):141-146.
PubMedGoogle Scholar 22.Loprinzi
PD , Kohli
M . Effect of physical activity and sedentary behavior on serum prostate-specific antigen concentrations: results from the National Health and Nutrition Examination Survey (NHANES), 2003-2006.
Mayo Clin Proc. 2013;88(1):11-21. doi:
10.1016/j.mayocp.2012.10.012
PubMedGoogle ScholarCrossref 24.Stofan
JR , DiPietro
L , Davis
D , Kohl
HW
III , Blair
SN . Physical activity patterns associated with cardiorespiratory fitness and reduced mortality: the Aerobics Center Longitudinal Study.
Am J Public Health. 1998;88(12):1807-1813. doi:
10.2105/AJPH.88.12.1807
PubMedGoogle ScholarCrossref 26.Cormie
P , Galvão
DA , Spry
N ,
et al. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
BJU Int. 2015;115(2):256-266. doi:
10.1111/bju.12646
PubMedGoogle ScholarCrossref 27.Galvão
DA , Spry
N , Denham
J ,
et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
Eur Urol. 2014;65(5):856-864. doi:
10.1016/j.eururo.2013.09.041
PubMedGoogle ScholarCrossref 28.Galvão
DA , Taaffe
DR , Spry
N , Joseph
D , Newton
RU . Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial.
J Clin Oncol. 2010;28(2):340-347. doi:
10.1200/JCO.2009.23.2488
PubMedGoogle ScholarCrossref 35.Carter
HB , Ferrucci
L , Kettermann
A ,
et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
J Natl Cancer Inst. 2006;98(21):1521-1527. doi:
10.1093/jnci/djj410
PubMedGoogle ScholarCrossref 40.Ngo
TH , Barnard
RJ , Tymchuk
CN , Cohen
P , Aronson
WJ . Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States).
Cancer Causes Control. 2002;13(10):929-935. doi:
10.1023/A:1021911517010
PubMedGoogle ScholarCrossref 46.Lee
K , Zhou
J , Norris
MK , Chow
C , Dieli-Conwright
CM . Prehabilitative exercise for the enhancement of physical, psychosocial, and biological outcomes among patients diagnosed with cancer.
Curr Oncol Rep. 2020;22(7):71. doi:
10.1007/s11912-020-00932-9
PubMedGoogle ScholarCrossref 48.Galvão
DA , Hayne
D , Frydenberg
M ,
et al. Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial.
BMJ Open. 2018;8(4):e022331. doi:
10.1136/bmjopen-2018-022331
PubMedGoogle Scholar